๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt induced hypertensive rats

โœ Scribed by Kye S. Han; Sun H. Lee; Myung G. Lee; Nak D. Kim


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
810 KB
Volume
14
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

The pharmacokinetics and pharmacodynamics of bumetanide were investigated after intravenous (i.v.) administration, 10 mg kg^โˆ’1^, and oral administration, 20 mg kg^โˆ’1^, to spontaneously hypertensive rats (SHRs) and deoxycorticosterone acetateโ€salt induced hypertensive rats (DOCAโ€salt rats). After i.v. administration, the pharmacokinetic and pharmacodynamic parameters of bumetanide did not vary significantly between SHRs and the control Wistar rats. Similar results were also shown between DOCAโ€salt rats and the control Spragueโ€Dawley (SD) rats. After oral administration, the AUC~0โ€“12 h~ decreased significantly (186 versus 335 ฮผg min ml^โˆ’1^) in SHRs and this resulted in decreased F(15.4 versus 23.6 and 2.78 versus 5.76% using two equations) in SHRs when compared with the control Wistar rats, although none of the other pharmacokinetic parameters varied significantly between SHRs and Wistar rats. This effect seemed to be due to the decreased enterohepatic recirculation of bumetanide in SHRs: the amounts of both bumetanide and its glucuronide product, which are capable of enterohepatic recirculation, excreted in 8 h bile juice decreased significantly in SHRs (11.3 versus 37.4 ฮผg as expressed in terms of bumetanide) when compared with Wistar rats. The pharmacodynamic parameters did not vary significantly between SHRs and Wistar rats after oral administration of bumetanide. The pharmacokinetic and pharmacodynamic parameters of bumetanide did not vary significantly between DOCAโ€salt rats and SD rats after oral administration of the drug. The liver weights compared to body weight increased significantly in SHRs when compared with Wistar rats and the corresponding values for the kidney increased significantly in DOCAโ€salt rats when compared with SD rats.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of a new proton pump in
โœ Ho J. Kim; Kye S. Han; Yoon G. Kim; Young-K. Chung; Man S. Chang; Myung G. Lee ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 1 views

## Abstract The purpose of this study was to investigate the causes for the differences observed in the pharmacokinetics of YJAโ€20379โ€8 in 16โ€weekโ€old spontaneously hypertensive rats (SHRs). To see if the hereditary characteristics of SHRs was the cause, 20 mg/kg of the drug was intravenously infus

Pharmacokinetic and pharmacodynamic chan
โœ Joo H. Park; Woo I. Lee; Woo H. Yoon; Young-D. Park; Jung-S. Lee; Myung G. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 163 KB ๐Ÿ‘ 3 views

Because some physiological changes occurring in diabetes mellitus patients could alter the pharmacokinetics and pharmacodynamics of the drugs to treat the disease, the pharmacokinetics and pharmacodynamics of furosemide were investigated after intravenous (i.v.) and oral administration of the drug (

Pharmacokinetic and pharmacodynamic chan
โœ Kwang J. Park; Woo H. Yoon; Sung H. Kim; Wan G. Shin; Myung G. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB ๐Ÿ‘ 3 views

The pharmacokinetic and pharmacodynamic differences of azosemide were investigated after intravenous (IV) and oral administration of azosemide, 10 mg kg -1 , to the control and uranyl nitrate-induced acute renal failure (U-ARF) rats. After IV administration, the plasma concentrations of azosemide we